Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

NCT00191503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma

Interventions

DRUG: Pemetrexed
DRUG: Gemcitabine

Sponsor

Eli Lilly and Company